This paper simplifies and encapsulates the past, present and future for developing vaccines, especially against AIDS.
Needed technical information and how it can best be obtained are delineated.
The views are my own and may not be shared by others.
The science enterprise, including that for vaccines, is enmeshed in the major evolution and restructuring of many of the world's institutions.
Changes brought by the knowledge revolution impinge on scientific information, technology, public policy. societal demands, private and public funding, academic and industrial organization and economic opportunity.
Public-supported research is not an entitlement, It is in the scientific establishment's best interest to organize for greatest efficiency and effectiveness to bring paybacks commensurate with public investment.
Mots-clés Pascal : Virus immunodéficience humaine, Lentivirus, Retroviridae, Virus, Vaccin, Recherche développement, Recherche scientifique, Historique, Financement, Commercialisation, Aspect économique, SIDA, Virose, Infection, Immunopathologie, Immunodéficit
Mots-clés Pascal anglais : Human immunodeficiency virus, Lentivirus, Retroviridae, Virus, Vaccine, Research and development, Scientific research, Case history, Financing, Marketing, Economic aspect, AIDS, Viral disease, Infection, Immunopathology, Immune deficiency
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0225544
Code Inist : 002B05A02. Création : 16/11/1999.